ATR
AptarGroup, Inc (ATR) Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray
AptarGroup, Inc (NYSE: ATR) FY 2026 Other Release
AptarGroup, Inc (ATR) Sec Form 8K
AptarGroup, Inc (NYSE: ATR) Sec Form 8K
AptarGroup, Inc (ATR) Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year
AptarGroup, Inc (NYSE: ATR) FY 2026 Management Update
AptarGroup, Inc (ATR) Aptar’s Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN Nasal Spray
AptarGroup, Inc (NYSE: ATR) FY 2026 Other Release
AptarGroup, Inc (ATR) Q4 2025 Earnings Call Transcript
AptarGroup, Inc (NYSE: ATR) Q4 2025 Earnings Call dated Feb. 06, 2026 Corporate Participants: Mary Skafidas — Senior Vice President,…
AptarGroup, Inc (ATR) The Raymond James 2026 Institutional Investors Conference
AptarGroup, Inc (NYSE: ATR) FY 2026 Corporate Conference
AptarGroup, Inc (ATR) The Bank of America Securities 2026 Global Agriculture and Materials Conference
AptarGroup, Inc (NYSE: ATR) FY 2026 Corporate Conference
AptarGroup, Inc (ATR) Sec Form 10K
AptarGroup, Inc (NYSE: ATR) Sec Form 10K
AptarGroup, Inc (ATR) Sec Form 8K
AptarGroup, Inc (NYSE: ATR) Sec Form 8K
AptarGroup, Inc. (ATR) Shares Rise on Q4 Revenue Beat Amid Margin Pressure
Shares of AptarGroup, Inc. (ATR) advanced modestly following the release of fourth-quarter and full-year 2025 results on February 5, 2026,…